B

BioMotiv

6 employees

BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.

Investor insights

Sectors invested in

Biotechnology5

Drug Discovery4

Health Care3

Medical3

Pharmaceutical3

Genetic Medicine2

Chemistry2

Biology2

Targeted Protein Degradation2

Biopharma2

Tissue-specific Targeting2

Licensing2

Bispecifics2

Protein Conjugation2

Protein Engineering2

Drug Delivery2

siRNA2

Therapeutics2

Protein Therapeutics2

Immunology2

Funding rounds participated in

$10M sweet spot round size

Most of their 6 investments are in rounds between $1.6M and $53M

Investor type

Accelerator

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Life Science

Therapeutics

Medical

Date founded

2012

Investments made

A

Amphista Therapeutics Limited raised $53M on March 17, 2021

Investors: Forbion, Advent Life Sciences, Gilde Healthcare and BioMotiv

A

Aro Biotherapeutics raised $88M on January 5, 2021

Investors: Ionis Pharmaceuticals, Inc., Ridgeback Capital Management LLC, HealthCap, Northpond Ventures and BioMotiv

A

Amphista Therapeutics Limited raised $7.5M on April 7, 2020

Investors: Advent Life Sciences and BioMotiv

A

Aro Biotherapeutics raised $13M on December 11, 2018

Investors: BioMotiv

U

Undisclosed raised $1.6M on January 27, 2017

Investors: BioCrossroads, Indiana University Research and Technology Corporation and BioMotiv

O

ORCA PHARMACEUTICALS LIMITED raised $1.3M on April 28, 2014